These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17005038)

  • 1. Responsiveness and minimal important differences for patient reported outcomes.
    Revicki DA; Cella D; Hays RD; Sloan JA; Lenderking WR; Aaronson NK
    Health Qual Life Outcomes; 2006 Sep; 4():70. PubMed ID: 17005038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.
    ; ;
    Health Qual Life Outcomes; 2006 Oct; 4():79. PubMed ID: 17034633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.
    Brozek JL; Guyatt GH; Schünemann HJ
    Health Qual Life Outcomes; 2006 Sep; 4():69. PubMed ID: 17005037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier.
    Revicki DA; Gnanasakthy A; Weinfurt K
    Qual Life Res; 2007 May; 16(4):717-23. PubMed ID: 17268927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.
    Revicki D; Hays RD; Cella D; Sloan J
    J Clin Epidemiol; 2008 Feb; 61(2):102-9. PubMed ID: 18177782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes: conceptual issues.
    Rothman ML; Beltran P; Cappelleri JC; Lipscomb J; Teschendorf B;
    Value Health; 2007; 10 Suppl 2():S66-75. PubMed ID: 17995476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is sufficient evidence for the reliability and validity of patient-reported outcome measures?
    Frost MH; Reeve BB; Liepa AM; Stauffer JW; Hays RD;
    Value Health; 2007; 10 Suppl 2():S94-S105. PubMed ID: 17995479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes to support medical product labeling claims: FDA perspective.
    Patrick DL; Burke LB; Powers JH; Scott JA; Rock EP; Dawisha S; O'Neill R; Kennedy DL
    Value Health; 2007; 10 Suppl 2():S125-37. PubMed ID: 17995471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
    Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
    Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-reported outcome instrument selection: designing a measurement strategy.
    Snyder CF; Watson ME; Jackson JD; Cella D; Halyard MY;
    Value Health; 2007; 10 Suppl 2():S76-85. PubMed ID: 17995477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
    Acquadro C; Berzon R; Dubois D; Leidy NK; Marquis P; Revicki D; Rothman M;
    Value Health; 2003; 6(5):522-31. PubMed ID: 14627058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
    Cleeland CS; Sloan JA;
    J Pain Symptom Manage; 2010 Jun; 39(6):1077-85. PubMed ID: 20538189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-reported outcomes supporting anticancer product approvals.
    Rock EP; Kennedy DL; Furness MH; Pierce WF; Pazdur R; Burke LB
    J Clin Oncol; 2007 Nov; 25(32):5094-9. PubMed ID: 17991927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.
    Rothman M; Burke L; Erickson P; Leidy NK; Patrick DL; Petrie CD
    Value Health; 2009; 12(8):1075-83. PubMed ID: 19804437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROs: defining clinical benefit from the patient's perspective. Draft guidance provides direction in evaluating patient-reported outcomes.
    Pazdur R
    Oncology (Williston Park); 2006 May; 20(6):660. PubMed ID: 16773848
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
    Dubois D; Gilet H; Viala-Danten M; Tack J
    Neurogastroenterol Motil; 2010 Feb; 22(2):e54-63. PubMed ID: 19761492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes: instrument development and selection issues.
    Turner RR; Quittner AL; Parasuraman BM; Kallich JD; Cleeland CS;
    Value Health; 2007; 10 Suppl 2():S86-93. PubMed ID: 17995478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.